Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiorenal Syndrome Revisited
Faı̈ez Zannad, Patrick Rossignol
Circulation (2018) Vol. 138, Iss. 9, pp. 929-944
Open Access | Times Cited: 270

Showing 1-25 of 270 citing articles:

Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology
Wilfried Müllens, Kevin Damman, Jeffrey M. Testani, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 4, pp. 584-603
Open Access | Times Cited: 314
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
Stefan Frantz, Moritz Hundertmark, Jeanette Schulz‐Menger, et al.
European Heart Journal (2022) Vol. 43, Iss. 27, pp. 2549-2561
Open Access | Times Cited: 308
Heart failure drug treatment
Patrick Rossignol, Adrian F. Hernandez, Scott D. Solomon, et al.
The Lancet (2019) Vol. 393, Iss. 10175, pp. 1034-1044
Open Access | Times Cited: 294
The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases
Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez, Julio M. Martínez‐Moreno, et al.
Biomolecules (2020) Vol. 10, Iss. 2, pp. 347-347
Open Access | Times Cited: 197
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial
Gerasimos Filippatos, Stefan D. Anker, Rajiv Agarwal, et al.
Circulation (2021) Vol. 145, Iss. 6, pp. 437-447
Open Access | Times Cited: 169
Kidney Function and Outcomes in Patients Hospitalized With Heart Failure
Ravi B. Patel, Gregg C. Fonarow, Stephen J. Greene, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 4, pp. 330-343
Open Access | Times Cited: 140
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 98
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology
Julio Núñez, Rafael de la Espriella, Patrick Rossignol, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1751-1766
Open Access | Times Cited: 92
Chronic Kidney Disease as a Comorbidity in Heart Failure
Magdalena Szlagor, Jill Dybiec, Ewelina Młynarska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2988-2988
Open Access | Times Cited: 52
Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies
Bo Zhao, Xinrong Hu, Weidong Wang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 2
Abnormalities of Potassium in Heart Failure
João Pedro Ferreira, Javed Butler, Patrick Rossignol, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 22, pp. 2836-2850
Open Access | Times Cited: 126
Cardiovascular Consequences of Acute Kidney Injury
Matthieu Legrand, Patrick Rossignol
New England Journal of Medicine (2020) Vol. 382, Iss. 23, pp. 2238-2247
Open Access | Times Cited: 101
FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
Ineke Böckmann, Jonas Lischka, Beatrice Richter, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4634-4634
Open Access | Times Cited: 88
The role of miR‐29 family in disease
Masahiro Horita, Colin Farquharson, Louise A. Stephen
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 7, pp. 696-715
Open Access | Times Cited: 81
Management of Heart Failure Patient with CKD
Debasish Banerjee, Giuseppe Rosano, Charles A. Herzog
Clinical Journal of the American Society of Nephrology (2021) Vol. 16, Iss. 7, pp. 1131-1139
Open Access | Times Cited: 69
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
Alexandros Kasiakogias, Enrico Agabiti Rosei, Miguel Camafort, et al.
Journal of Hypertension (2021) Vol. 39, Iss. 8, pp. 1522-1545
Open Access | Times Cited: 56
Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
Jonathan P. Law, Luke Pickup, Davor Pavlović, et al.
Journal of Human Hypertension (2022) Vol. 37, Iss. 1, pp. 1-19
Open Access | Times Cited: 50
Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease
Chih‐Yuan Niu, Shang‐Feng Yang, Shuo‐Ming Ou, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 18
Open Access | Times Cited: 47
Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench
Xin Chen, Carl‐Friedrich Hocher, Linghong Shen, et al.
AJP Cell Physiology (2023) Vol. 325, Iss. 3, pp. C661-C681
Closed Access | Times Cited: 30
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
Pantelis Sarafidis, Fotini Iatridi, Charles J. Ferro, et al.
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1885-1907
Open Access | Times Cited: 23
Total-Body PET/CT Applications in Cardiovascular Diseases: A Perspective Document of the SNMMI Cardiovascular Council
Riemer H. J. A. Slart, Frank M. Bengel, Çiğdem Akincioğlu, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 4, pp. 607-616
Closed Access | Times Cited: 9
Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease
Cuicui Xu, George Tsihlis, Katrina Chau, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2658-2658
Open Access | Times Cited: 8
Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF
Samir Patel, Venkatesh K. Raman, Charles Faselis, et al.
JACC Heart Failure (2025)
Closed Access | Times Cited: 1
Cardiorenal Syndrome and Heart Failure—Challenges and Opportunities
Haran Yogasundaram, Mark C. Chappell, Branko Braam, et al.
Canadian Journal of Cardiology (2019) Vol. 35, Iss. 9, pp. 1208-1219
Open Access | Times Cited: 65
Urinary peptides in heart failure: a link to molecular pathophysiology
Tianlin He, Michaela Mischak, Andrew L. Clark, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 11, pp. 1875-1887
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top